According to a November 13 Bloomberg report, strategists at a major Wall Street bank expect the S&P 500 to reach 8,700 within 12 months. They also see earnings growth slowing to 11% in 2027 from 36% in 2026. That gap matters because slower profit growth changes what investors reward. According to the report, buyers are willing to pay up for companies that keep growing, because growth is becoming harder to find. For stock pickers, that raises the value of any name where earnings momentum is still intact. It matters most when the market has not yet priced all of it in.
Slower Profit Growth Raises the Bar
On November 13, chip stocks sold off and the S&P 500 fell 0.4%, although it still gained about 2.5% on the week, according to Yahoo Finance’s market coverage. Wholesale inflation also reached its highest annual rate in nearly four years, and the 10-year Treasury yield closed at 5.15% on November 13. Higher yields make future earnings worth less today. That is one reason the largest technology companies have drawn scrutiny, since their spending has pushed free cash flow negative. Even so, Bloomberg’s report described them as “relatively defensive.” Readers who want a broader look at the rebound case can see our ranking of oversold AI stocks where Wall Street analysts see big upside.
What a Price Target Really Means
A price target is an analyst’s estimate of where a stock should trade in about 12 months, built from forecasts for earnings, growth, and a reasonable valuation multiple. Upside is simply the gap between today’s share price and the average of those targets, expressed as a percentage. Because targets are opinions rather than guarantees, they can move quickly after a company reports, and a cut does not always mean the analyst has turned negative. Sometimes a firm trims its target to reflect a stock that has already risen, or an expectations bar that was set too high, while keeping a positive rating.
That is why the rating and the target are best read together. An upgrade with a lower target tells a different story from a reiterated rating with a higher one. The reasons behind a change, such as delayed contracts, better cost control or a pricing shift, usually say more than the number does. Ranking by average upside adds a second layer. A large gap to the average target can point to a stock that has fallen out of favor as easily as to one analysts expect to take off. Our list of NYSE-listed stocks with large analyst-estimated upside shows how wide that spread can get on a single exchange. Following the reasons as well as the numbers keeps that distinction clear.

Our Methodology
To compile this list, we looked at the 15 US-listed stocks in Morgan Stanley’s Vintage Values 2027 portfolio and ranked them by average upside potential, based on analysts’ average price target. We then picked the 10 with the highest upside that had a full year of share price history and a positive share price performance over that period, and counted the list down from there. We also list each stock’s market cap and its share price performance over the past year.
Note: All data was sourced on November 16, 2026.
At Insider Monkey, we are obsessed with what hedge funds do. The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 612% since May 2014, beating its benchmark by 375 percentage points (see more details here).
Morgan Stanley’s Vintage Values 2027: 10 Stocks Analysts See Climbing Further
10. Eli Lilly (NYSE:LLY)
Market Cap: $1.37 trillion
Average Upside Potential: 4%
1-Year Performance: 41.66%
Jefferies raised its price target on Eli Lilly to $1,700 from $1,610 on November 9, 2026, the highest target on Wall Street. The firm argued that the international obesity market could be at least as large as the U.S. market, with about twice as many potential patients. It also said realized prices could rise as patients move to higher doses. Eli Lilly is a drugmaker whose diabetes and weight-loss medicines, Mounjaro and Zepbound, drive most of its growth.
Not every firm agrees. China Merchants Securities downgraded the stock to Hold from Buy on November 12, 2026.
The company reported results for the third quarter of 2026 on October 29, 2026. Revenue rose 39% to $24.4 billion on higher volume, though lower realized prices held back growth. Management credited broad global demand for Mounjaro and Zepbound and the launches of Foundayo, its oral obesity drug. Lilly raised its full-year revenue guidance, and Chief Executive Officer Dave Ricks said the third quarter exceeded the company’s prior expectations. Positive head-to-head results for retatrutide against Ozempic in type 2 diabetes added to the pipeline case. We covered whether Lilly’s growth can keep justifying its premium valuation in a separate piece.
9. McKesson (NYSE:MCK)
Market Cap: $128.62 billion
Average Upside Potential: 4%
1-Year Performance: 32.29%
UBS analyst Kevin Caliendo raised his price target on McKesson to $1,250 from $1,200 on November 5, 2026, and kept a Buy rating. McKesson is a healthcare distributor that supplies medicines and medical products to pharmacies, health systems and care providers.
The note followed results for the second quarter of fiscal 2027, ended September 30, 2026, which the company released on November 4, 2026. Revenue increased 8% to $111.0 billion, and adjusted earnings per share rose 18% to $11.68. McKesson also raised its full-year adjusted earnings per share guidance, and its oncology and multispecialty business grew faster than any other segment.
On October 5, 2026, the company agreed to take a minority stake in Option Care Health, a home and alternate-site infusion provider. On November 2, 2026, it completed the acquisition of Precision Medicine Group, a clinical research and biopharma commercialization firm. Executives said the Precision Medicine Group deal strengthens McKesson’s oncology and biopharma services platforms. Chief Executive Officer Brian Tyler described the Option Care Health investment as a way into home and community-based care, with Clayton, Dubilier & Rice holding the majority stake. Our take on whether the Option Care Health deal is justified covers the price paid.
8. Visa (NYSE:V)
Market Cap: $793.68 billion
Average Upside Potential: 7%
1-Year Performance: 29.69%
Morgan Stanley analyst James Faucette raised his price target on Visa to $471 from $416 on October 28, 2026, and maintained an Overweight rating. Visa runs a global digital payments network that connects consumers, merchants and financial institutions.
The call came a day after Visa released results for the fiscal fourth quarter of 2026, ended September 30, 2026, on October 27, 2026. Net revenue increased 13% to $12.1 billion, and non-GAAP earnings per share also came in above analyst estimates. For the full fiscal year, net revenue reached a record $45.9 billion. Chief Executive Officer Ryan McInerney called it a “milestone year.”
Growth in the underlying volumes stayed healthy as well. Cross-border volume excluding transactions within Europe rose 14%, payments volume and processed transactions both kept expanding, and the board raised the quarterly cash dividend. Visa also returned cash through repurchases and dividends, which adds a steady shareholder-return element to a business that earns revenue on every transaction crossing its network. McInerney said trust is the next growth vector for Visa as the company looks to fiscal 2027 and beyond. Our piece on how Visa turns scale into best-in-class margins explains why.
7. TransUnion (NYSE:TRU)
Market Cap: $15.52 billion
Average Upside Potential: 12%
1-Year Performance: 0.36%
Rothschild & Co Redburn downgraded TransUnion to Neutral from Buy on November 9, 2026, and set its price target at $91, up from $89. TransUnion is a global information and insights company best known for the credit reports and risk scores that lenders use to decide who gets credit.
That call followed results for the third quarter ended September 30, 2026, which the company released on October 27, 2026. Revenue grew 12% to $1.31 billion, and adjusted earnings per share rose 14%. Chief Executive Officer Chris Cartwright pointed to international growth, with India accelerating to double digits.
TransUnion raised its full-year adjusted earnings per share guidance, and the board lifted its share repurchase authorization and its quarterly dividend. One soft spot was profitability: the adjusted EBITDA margin narrowed to 35.4% from the level a year earlier. It still expects a third consecutive year of at least high single-digit organic constant-currency revenue growth. Growth in the United States was led by financial services and insurance, and the Mexico acquisition added to results abroad. We weighed it against its closest peer in our comparison with Equifax.
6. Liberty Formula One (NASDAQ:FWONK)
Market Cap: $27.45 billion
Average Upside Potential: 12%
1-Year Performance: 11.26%
Goldman Sachs analyst Stephen Laszczyk raised his price target on Liberty Formula One to $120 from $116 on November 6, 2026, and kept a Buy rating. He pointed to stronger hospitality revenue at Formula 1 and better race promotion at MotoGP. The stock tracks Liberty Media’s Formula 1 business, which holds the exclusive commercial rights to the sport’s world championship. It also includes MotoGP, the motorcycle racing series.
Liberty Media reported results for the third quarter of 2026 on November 5, 2026. Formula 1 revenue rose 28% to $1,115 million, helped by one more race than in the same period a year earlier. Adjusted OIBDA climbed 44% to $338 million. Higher hospitality revenue at recurring events lifted the non-race side of the business.
The company announced a ten-year agreement to hold the African Grand Prix in Rwanda beginning in the early 2030s. It also extended its broadcast agreement with DAZN in Spain, Portugal and Andorra through 2030. Liberty also pointed to a new race-weekend format for MotoGP in 2027, part of its goal of accelerating the sport’s global growth. Results arrived a day before Goldman Sachs published its updated view.
5. Equinix (NASDAQ:EQIX)
Market Cap: $104.31 billion
Average Upside Potential: 17%
1-Year Performance: 34.14%
Raymond James reiterated its Strong Buy rating on Equinix on October 29, 2026, with a $1,250 price target. The firm pointed to the raised guidance and to pricing about 12% higher on new deployments. Equinix is a digital infrastructure company that operates data centers where businesses connect their networks and cloud services.
The company released results for the third quarter of 2026 on October 28, 2026. Revenue rose 11% to $2.571 billion, and record annualized gross bookings reached $533 million, up 35%. It was the third consecutive time Equinix raised its full-year 2026 guidance. Chief Executive Officer Adaire Fox-Martin said the results reflect the company’s growing importance, citing double-digit growth in interconnection and monthly recurring revenue.
Equinix is also moving faster on supply, planning many more cabinets for delivery in 2026 than first anticipated. It introduced Fabric One, a connectivity service for distributed cloud, network and AI environments, along with an inference exchange built with partners. It also completed its investment in atNorth, which expands its Nordic footprint with high-density capacity powered by renewable energy. The company’s path from a 1998 data center operator to an AI player is told in our earlier profile of Equinix.
4. Amazon (NASDAQ:AMZN)
Market Cap: $2.86 trillion
Average Upside Potential: 24%
1-Year Performance: 12.66%
Morgan Stanley analyst Brian Nowak lowered his price target on Amazon to $335 from $350 on October 30, 2026, and kept an Overweight rating. The reason was about expectations, not weakness. Amazon Web Services added about $3.8 billion in revenue from the second quarter to the third. That was the second-largest increase in its history, yet it fell short of what investors hoped to see. Amazon is an online retailer that also owns Amazon Web Services, its cloud business.
The company released results for the third quarter of 2026 on October 29, 2026. AWS revenue grew 39%, its fastest pace in nearly five years, and total operating income reached $28.1 billion at the highest operating margin Amazon has reported. Earnings per share came in a little below analyst estimates.
Chief Executive Officer Andy Jassy said AWS is projected to grow more than 40% in both 2027 and 2028. He added that broader selection and faster delivery are helping Amazon win retail share with improving margins. He also pointed to newer businesses, from grocery and pharmacy to Zoox, as progressing encouragingly. Our piece on whether Amazon’s cash engines can fund its robotaxi bet picks up that thread.
3. Williams Companies (NYSE:WMB)
Market Cap: $86.36 billion
Average Upside Potential: 25%
1-Year Performance: 13.26%
Goldman Sachs kept a Buy rating on Williams on November 12, 2026, while lowering its price target to $82 from $84. Williams is an energy infrastructure company built around natural gas pipelines, storage and gathering.
The cut followed Williams’ third-quarter 2026 results, released on November 2, 2026. Adjusted EBITDA rose 6% to $2.039 billion and adjusted earnings per share climbed 10%. The company said it is tracking toward the upper half of its 2026 adjusted EBITDA guidance range. Cash generation also improved, and the dividend was covered by a comfortable margin on an available-funds basis.
Growth projects continue to arrive. Williams closed its acquisition of Momentum Midstream on September 3, 2026, which strengthens its Haynesville position for LNG, industrial and power demand. It announced a storage expansion at Clay Basin and expects its Plato North power project to be in service by mid-November. Chief Executive Officer Chad Zamarin has targeted adjusted EBITDA growth of at least 11% a year through 2030. That gives the Buy case a clear growth target to measure against, and the dividend remains well covered by cash flow. For more on what protects those returns, see our look at the company’s economic moat.
2. Alphabet (NASDAQ:GOOGL)
Market Cap: $3.57 trillion
Average Upside Potential: 33%
1-Year Performance: 6.28%
BMO Capital Markets cut its price target on Alphabet to $425 from $480 on October 29, 2026, while keeping its Outperform rating. Alphabet is the holding company behind Google Services, Google Cloud and Other Bets, the group that houses its longer-term projects.
The cut came a day after the company released results for the third quarter of 2026 on October 28, 2026. Revenue reached $127.6 billion, and Google Cloud revenue grew 103%, with its backlog standing at $561 billion. Search revenue growth of 12% was below what at least one other firm had modeled.
Chief Executive Officer Sundar Pichai said Alphabet is now on a half-trillion-dollar annual revenue run rate. He said the Gemini app has reached one billion users, which he called the fastest-growing product in Google’s history, and that Search query growth is the highest in five years. Subscriptions, platforms and devices revenue grew, driven by YouTube subscriptions and demand for AI plans in Google One. Pichai added that usage of the new Gemini 4 model ramped up three-and-a-half times faster than Gemini 3 in its first week, even with capacity constraints. We also examined whether Alphabet’s valuation reflects Waymo’s potential in a separate piece.
1. Keysight Technologies (NYSE:KEYS)
Market Cap: $48.55 billion
Average Upside Potential: 49%
1-Year Performance: 59.28%
Goldman Sachs analyst Mark Delaney raised his price target on Keysight to $487 from $452 on October 6, 2026, and kept a Buy rating, pointing to strong demand for AI infrastructure. Keysight makes the electronic design and test equipment that engineers use to check chips, data centers and communications networks.
The company reported results for its fiscal third quarter, ended July 31, 2026, on August 18, 2026. Revenue rose 36% to $1.85 billion, and non-GAAP earnings per share reached $3.07. Growth came across both segments, led by commercial communications, where demand tied to AI data centers was strongest. Orders grew faster than revenue, and free cash flow rose from a year earlier. Management raised its outlook for the fourth quarter and the full year, though it noted supply constraints. Chief Executive Officer Satish Dhanasekaran said the record results reflect the growing relevance of the company’s strategy and portfolio.
Keysight is expected to report its next quarterly results on November 19, 2026, and analysts expect earnings of $3.37 per share. Whether AI-driven demand keeps this pace is the question for that report. Our look at whether AI testing is becoming a durable growth engine explores it.
READ NEXT: Alphabet (GOOGL): Can YouTube Subscriptions Make Its Earnings More Resilient? and Amazon (AMZN): How Much More Can It Earn From Sellers Before Their Economics Suffer?





